Characterization of Post Coronary Artery Bypass Grafting Atrial Fibrillation Patterns – Atrial Pathophysiology Substudy

Characterization of Post Coronary Artery Bypass Grafting Atrial Fibrillation Patterns – Atrial Pathophysiology Substudy - CABG-AF APS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025562

Enrollment

Registered

2021-06-10

Start date

2021-07-05

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I48.0

Interventions

Group 1: In the CABG-AF study Insertable Cardiac Montiors will be implanted in in the thoracic subcutaneous tissue of patients receiving coronary artery bypass surgery. Using the data collected via th

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Three vessel coronary artery disease or left mainstem disease 2. = 2 coronary artery bypass grafts performed 3. Preoperative left ventricular ejection fraction = 35 % 4. Preoperative sinus rhythm 5. Age > 18 years

Exclusion criteria

Exclusion criteria: 1. Any history of atrial fibrillation, atrial flutter or atrial tachycardia 2. Any history of the following complex rhythm disorders: I. Sinoatrial block II. Sick sinus syndrome III. Atrioventricular block > Grade 1 IV. AV node reentry tachycardia V. AV reentry tachycardia VI. Focal atrial tachycardia VII. Accelerated junctional rhythm VIII. Ventricular tachycardia IX. Ventricular fibrillation X. Long-QT syndrome 3. Valvular heart disease 4. Concurrent cardiac surgery (valve surgery, aortic surgery, surgical ablation) 5. Pre- or postoperative mechanical circulatory support (failure to wean from cardiopulmonary bypass machine / intraaortic balloon pump / extracorporeal membrane oxygenation / Impella® device) 6. Repeat cardiac surgery 7. LVEF < 35 % 8. Age = 18 years 9. Life expectancy < 1 year 10. Doubtful patient compliance

Design outcomes

Primary

Measure	Time frame
No primary outcome. Aim of the study: to further the understanding of the atrial pathophysiology of atrial fibrillation after CABG.	—

Secondary

Measure	Time frame
See primary outcome.	—

Countries

Germany

Contacts

Public ContactFlorian Herrmann

Herzklinik der Universität München am Augustinum, LMU Klinikum

Florian.Herrmann@med.uni-muenchen.de0152 5488 9442

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 27, 2026